ARA-290 Peptide – Research Grade EPO-Derived Tissue Protective Peptide

Product Overview

ARA-290 Peptide is a synthetic research peptide derived from the helix B region of human erythropoietin (EPO). Also known as Cibinetide or Helix B Surface Peptide (HBSP), ARA-290 was designed as a molecular research tool to investigate non-hematopoietic signaling pathways associated with erythropoietin biology.

Unlike traditional EPO research focusing on erythropoiesis, ARA-290 research primarily explores tissue protective signaling, cellular response mechanisms, inflammation-related pathways, and molecular interactions.

ARA-290 is supplied as a research-grade peptide compound for biotechnology companies, pharmaceutical research organizations, and academic laboratories.

1. What is ARA-290 Peptide? (Identity & Positioning)

Identity & Research Positioning

ARA-290 is a synthetic peptide based on a specific functional region of erythropoietin (EPO), developed to study EPO-related protective signaling pathways without focusing on classical erythropoietic activity.

Product Identity

ARA-290 is widely studied as a research compound for understanding cellular protection mechanisms and receptor-mediated signaling pathways.

2. Peptide Category Positioning

Research Peptide Classification

ARA-290 belongs to the following research peptide categories:

Primary Category

EPO-Derived Tissue Protective Research Peptide

Secondary Categories

• Cytoprotective Research Peptide

• Cell Signaling Research Peptide

• Immunology Research Compound

• Neurobiology Research Peptide

• Inflammation Pathway Research Tool

• Molecular Biology Research Peptide

3. Research Logic & Development Background

Scientific Research Rationale

ARA-290 was developed from studies exploring the biological functions of erythropoietin beyond its traditional role in red blood cell regulation.

Research has suggested that EPO-related signaling may involve different receptor interactions associated with cellular protection pathways.

ARA-290 was designed based on the Helix B surface region of EPO to investigate:

• Tissue protective signaling mechanisms

• Cellular stress response pathways

• Inflammation-related molecular pathways

• Receptor-mediated biological interactions

The research concept focuses on studying the interaction between peptide structures and protective cellular signaling networks.

4. Research Findings (Research Evidence)

Published Research Areas

ARA-290 has been investigated in multiple preclinical research fields.

1. Cellular Protection Research

Research studies have explored ARA-290 in relation to:

• Cellular stress responses

• Protective signaling pathways

• Molecular mechanisms involved in cell survival

2. Inflammation Pathway Research

ARA-290 has been studied as a tool for investigating:

• Inflammatory signaling mechanisms

• Immune response regulation

• Cytokine-related pathways

3. Neuroscience Research

Research applications include investigation of:

• Neural cell signaling

• Neurobiology mechanisms

• Cellular responses under stress conditions

4. Molecular Signaling Studies

ARA-290 is used in research exploring:

• Peptide-receptor interactions

• Intracellular signaling pathways

• Structure-function relationships

5. Research Applications

Laboratory Research Applications

ARA-290 Peptide may be used in qualified research environments for:

6. Safety Profile

Research Safety Considerations

ARA-290 is an experimental research peptide and has not been approved as a pharmaceutical compound.

Although ARA-290 is derived from an endogenous protein region, research-grade peptide products should only be evaluated within controlled laboratory environments.

Important considerations:

• Human safety profiles are not established for research applications.

• Long-term effects require further investigation.

• Biological activity depends on experimental conditions.

• Researchers should follow institutional laboratory procedures.

7. Final Product Positioning

Research Grade ARA-290 Peptide

ARA-290 Peptide is positioned as:

A high-quality synthetic EPO-derived research peptide designed for studies involving tissue protective signaling, cellular response pathways, and molecular biology applications.

Target Customers

Suitable for:

• Biotechnology Companies

• Pharmaceutical Research Laboratories

• Universities

• Academic Research Centers

• Life Science Organizations

Product Advantages

✓ Synthetic EPO-derived peptide
✓ Designed for molecular signaling research
✓ Suitable for cellular response studies
✓ Supports inflammation and neuroscience research applications
✓ Available with analytical quality documentation

8. Quality Documentation

Analytical Quality Documentation

Each ARA-290 peptide batch may include comprehensive quality verification records.

Certificate of Analysis (COA)

COA documentation provides:

• Product identification

• Batch number

• Purity testing results

• Quality specifications

• Analytical verification information

HPLC Report

High Performance Liquid Chromatography testing provides:

• Peptide purity analysis

• Chromatographic profile

• Quality assessment data

Mass Spectrometry

Mass spectrometry analysis confirms:

• Molecular weight

• Peptide identity

• Structural verification

Batch Documentation

Batch documentation may include:

• Manufacturing records

• Quality control information

• Batch traceability data

• Testing documentation

9. Storage Information

Recommended Storage Conditions

For maintaining peptide stability:

• Store in a sealed container

• Protect from moisture and contamination

• Maintain recommended laboratory storage conditions

• Avoid unnecessary freeze-thaw cycles

• Follow supplier handling guidelines

Storage requirements may vary depending on formulation and packaging specifications.

10. Research Disclaimer

Research Use Only Statement

ARA-290 Peptide is supplied strictly for laboratory research purposes.

For research use only.

Not intended for human consumption.

Not intended for clinical or diagnostic use.

This product is not a pharmaceutical product, dietary supplement, medical treatment, or therapeutic agent.

Customers are responsible for ensuring compliance with applicable research regulations and institutional requirements.

11. FAQ – B2B SEO Questions

1. What is ARA-290 peptide used for in research?

ARA-290 peptide is used as a research tool for studying EPO-derived signaling pathways, cellular protection mechanisms, and molecular biology processes.

2. Is ARA-290 an EPO-derived peptide?

Yes. ARA-290 is a synthetic peptide derived from the helix B region of erythropoietin and is studied for non-hematopoietic signaling research.

3. What research applications are associated with ARA-290 peptide?

ARA-290 is researched in areas including cell signaling, inflammation pathways, neuroscience research, and molecular biology studies.

4. How does ARA-290 differ from erythropoietin research compounds?

ARA-290 focuses on studying EPO-related protective signaling pathways rather than traditional erythropoietic functions.

5. What quality documents are available for ARA-290 peptide?

Research suppliers typically provide COA, HPLC reports, mass spectrometry analysis, and batch documentation for quality verification.

6. Who purchases ARA-290 research peptide?

Typical customers include biotechnology companies, pharmaceutical research organizations, academic laboratories, and life science institutions.

7. How should ARA-290 peptide be stored?

ARA-290 peptide should be stored according to supplier recommendations, protected from moisture, heat exposure, and repeated freeze-thaw cycles.

8. Is ARA-290 approved for clinical use?

No. ARA-290 is supplied strictly as a laboratory research compound and is not intended for human consumption, clinical use, or diagnostic applications.